NCT06485323 MRI Pseudo-CT Sequences for Obstetrical Pelvimetry.
| NCT ID | NCT06485323 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
| Condition | Obstetric Labor Complications |
| Study Type | INTERVENTIONAL |
| Enrollment | 95 participants |
| Start Date | 2023-07-05 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 95 participants in total. It began in 2023-07-05 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
It is possible to perform a pelvimetry by MRI as a substitute to pelvimetry by CT, hence sparing the patient from a dose of irradiation.
Eligibility Criteria
Inclusion Criteria: * Pregnant woman 33 to 41 week * Woman who gave birth by cesarean section, for whom the obstetrician requests a pelvimetry CT for the next pregnancy * Pelvimetry planned by the obstetrical team outside of "emergency" pathway * Adhere to the study protocol after reading the patient information document have signed the informed consent form to participate in the study Exclusion Criteria: * Usual contraindications to MRI (Pacemaker, Metallic foreign body, Cochlear implant,…) * Severe claustrophobia * uncomfortable back position
Contact & Investigator
Frédéric Lecouvet, MD, PhD
PRINCIPAL INVESTIGATOR
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Frequently Asked Questions
Who can join the NCT06485323 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 99 Years, studying Obstetric Labor Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06485323 currently recruiting?
Yes, NCT06485323 is actively recruiting participants. Contact the research team at frederic.lecouvet@saintluc.uclouvain.be for enrollment information.
Where is the NCT06485323 trial being conducted?
This trial is being conducted at Brussels, Belgium.
Who is sponsoring the NCT06485323 clinical trial?
NCT06485323 is sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain. The principal investigator is Frédéric Lecouvet, MD, PhD at Cliniques universitaires Saint-Luc- Université Catholique de Louvain. The trial plans to enroll 95 participants.